Literature DB >> 52678

A sandwich method of enzymoimmunoassay. I. Application to rat and human alpha-fetoprotein.

R Maiolini, R Masseyeff.   

Abstract

An enzymoimmunoassay (EIA) for the quantitation of soluble antigens having at least two antibody-combining sites is descirbed. This non-competitive sandwich method comprises three steps: 1) the antigen to be assayed is reacted with the antibody-coated cellulose immunosorbent, 2) the enzyme-labelled antibody is then incubated with the antigen bound to the solid phase, 3) the enzymatic activity of the immunosorbent is then measured. This activity increases with the quantity of antigen to be assayed. Examples of the application of this method to the assay of rat and human alpha-fetoprotein (AFP) are given. When applied to rat and human AFP, this assay gives reproducible results in the range of 10--1000 ng/ml and 3-1000 ng/ml respectively. AFP sera concentrations of normal and pregnant rats were assayed by EIA, radioimmunoassay RIA and rocket-immunoelectrophoresis (RIE). In all the cases good agreement was noted among these three techniques. Rheumatoid factor, whenever present, may interfere with the assay. However, the effect of this interaction can be eliminated. The advantages of the EIA method can be listed as follows: a) no pure antigen is required, b) the final color reaction is developed from the solid phase. This feature eliminates most non-specifically interfering factors, c) the range of the assay covers a 2 log-scale, d) only inexpensive equipment is used, e) results are obtained within 24 hr, f) sensitivity and reproducibility lie within a range comparable to that of RIA.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52678     DOI: 10.1016/0022-1759(75)90115-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  An antibody-lectin sandwich assay for quantifying protein glycoforms.

Authors:  F T Lundy; G B Wisdom
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

3.  Measurement of plasma concentrations of polymorphonuclear elastase-alpha 1 proteinase inhibitor (elastase-alpha 1 antitrypsin) in patients with rheumatoid arthritis: interference by rheumatoid factor.

Authors:  R E Banks; S W Evans; K F Taylor; H A Bird; J T Whicher
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

4.  A class capture enzyme immunoassay for immunoglobulin level determinations in bovine sera.

Authors:  K Nielsen; B Rosenbaum; J Stiller
Journal:  Can J Comp Med       Date:  1985-10

5.  Thyroid activity during hepatocarcinogenesis by N-2-fluorenylacetamide.

Authors:  C Stora; C Aussel; M Lafaurie; J L Formento
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

6.  Separation and purification of the hemagglutinins from Bordetella pertussis.

Authors:  Y Sato; J L Cowell; H Sato; D G Burstyn; C R Manclark
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

Review 7.  Enzyme immunoassays with special reference to ELISA techniques.

Authors:  A Voller; A Bartlett; D E Bidwell
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

8.  Immunoenzymatic determination of antibody-bound soluble antigens ofTrypanosoma cruzi.

Authors:  A Marcipar; S Barnes; E Lentwojt; G Broun
Journal:  Appl Biochem Biotechnol       Date:  1982-11       Impact factor: 2.926

9.  Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay.

Authors:  D S Burke; A Nisalak
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

10.  Enzyme immunoassay of teichoic acids from Listeria monocytogenes.

Authors:  K Kamisango; M Nagaoka; H Fujii; I Azuma
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.